Related Events

Reports from the Field

Mood stabilizer costs less, causes fewer side effects

Results of a head-to-head study showed fewer patients reported side effects with the mood stabilizer Depakote (divalproex sodium delayed-release tablets) compared to patients taking the antipsychotic olanzapine (Zyprexa), according to a study released at the annual meeting of the American College of Neuropsychopharmacology in San Juan, Puerto Rico.

In addition, for bipolar patients with acute mania, researchers found that there was no difference in the efficacy of the two drugs even though the cost of treating a patient with divalproex tablets is 50% lower than the cost of treating a patient with olanzapine.